Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Global Diabetes 2020: Health information Technologies in diabetes management

Eduardo J Simoes

About 1 in 11 adults worldwide now have DM, 90% of who have type 2 diabetes (T2D). Successful glycaemic control helps to prevent and reduce complications of T2D, including disorder, kidney disease, blindness, neuropathy, and limb amputation, and reduce death related to the disease. However, maintaining optimal glycemic control requires on-going monitoring and treatment, which can be costly and challenging. To reinforce diabetes management, the event of innovative self-care strategies is warranted. Advances in health information technologies (HITs) can have been introduced approaches that support effective and affordable health-care delivery and patient education. Technologies in the mobile, computer, e-mail, and Internet approaches have shown evidence in enhancing chronic disease management, suggesting great potential for diabetes management technologies. During this chapter, we provided a summary of the HITs in use for T2D management. We synthesized the foremost recent findings on HITs’ effect in reducing HbA1c and managing complications, cardiovascular conditions, especially. Further, we discussed limitations within the present research during this area and implications for future research. Last, we presented challenges of applying HITs in T2D management within the real-world context and suggested steps to maneuver forward.

Avertissement: Ce résumé a été traduit à l'aide d'outils d'intelligence artificielle et n'a pas encore été examiné ni vérifié.